These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 25047306)
41. The salience network in the apathy of late-life depression. Yuen GS; Gunning-Dixon FM; Hoptman MJ; AbdelMalak B; McGovern AR; Seirup JK; Alexopoulos GS Int J Geriatr Psychiatry; 2014 Nov; 29(11):1116-24. PubMed ID: 24990625 [TBL] [Abstract][Full Text] [Related]
42. Cognitive control, reward-related decision making and outcomes of late-life depression treated with an antidepressant. Alexopoulos GS; Manning K; Kanellopoulos D; McGovern A; Seirup JK; Banerjee S; Gunning F Psychol Med; 2015 Oct; 45(14):3111-20. PubMed ID: 26169527 [TBL] [Abstract][Full Text] [Related]
43. Modulation of the mineralocorticoid receptor as add-on treatment in depression: a randomized, double-blind, placebo-controlled proof-of-concept study. Otte C; Hinkelmann K; Moritz S; Yassouridis A; Jahn H; Wiedemann K; Kellner M J Psychiatr Res; 2010 Apr; 44(6):339-46. PubMed ID: 19909979 [TBL] [Abstract][Full Text] [Related]
44. Efficacy of escitalopram in patients with severe depression: a pooled analysis. Llorca PM; Azorin JM; Despiegel N; Verpillat P Int J Clin Pract; 2005 Mar; 59(3):268-75. PubMed ID: 15857321 [TBL] [Abstract][Full Text] [Related]
45. [Residual symptoms after a treated major depressive disorder: in practice ambulatory observatory carried out of city]. Mouchabac S; Ferreri M; Cabanac F; Bitton M Encephale; 2003; 29(5):438-44. PubMed ID: 14615693 [TBL] [Abstract][Full Text] [Related]
46. Depressive symptoms in late life: associations with apathy, resilience and disability vary between young-old and old-old. Mehta M; Whyte E; Lenze E; Hardy S; Roumani Y; Subashan P; Huang W; Studenski S Int J Geriatr Psychiatry; 2008 Mar; 23(3):238-43. PubMed ID: 17676651 [TBL] [Abstract][Full Text] [Related]
48. Escitalopram and duloxetine in major depressive disorder: a pharmacoeconomic comparison using UK cost data. Wade AG; Fernández JL; François C; Hansen K; Danchenko N; Despiegel N Pharmacoeconomics; 2008; 26(11):969-81. PubMed ID: 18850765 [TBL] [Abstract][Full Text] [Related]
49. Relationship of Apathy with Depressive Symptom Severity and Cognitive Functions in Geriatric Depression. Sözeri-Varma G; Bingöl C; Topak OZ; Enli Y; Özdel O Noro Psikiyatr Ars; 2019 Jun; 56(2):133-138. PubMed ID: 31223247 [TBL] [Abstract][Full Text] [Related]
50. The vasopressin V(1b) receptor antagonist SSR149415 in the treatment of major depressive and generalized anxiety disorders: results from 4 randomized, double-blind, placebo-controlled studies. Griebel G; Beeské S; Stahl SM J Clin Psychiatry; 2012 Nov; 73(11):1403-11. PubMed ID: 23146246 [TBL] [Abstract][Full Text] [Related]
51. Escitalopram (S-enantiomer of citalopram): clinical efficacy and onset of action predicted from a rat model. Montgomery SA; Loft H; Sánchez C; Reines EH; Papp M Pharmacol Toxicol; 2001 May; 88(5):282-6. PubMed ID: 11393591 [TBL] [Abstract][Full Text] [Related]
52. Citalopram versus amitriptyline in elderly depressed patients with or without mild cognitive dysfunction: a danish multicentre trial in general practice. Rosenberg C; Lauritzen L; Brix J; Jørgensen JB; Kofod P; Bayer LB Psychopharmacol Bull; 2007; 40(1):63-73. PubMed ID: 17285097 [TBL] [Abstract][Full Text] [Related]
53. Escitalopram dose-response revisited: an alternative psychometric approach to evaluate clinical effects of escitalopram compared to citalopram and placebo in patients with major depression. Bech P; Tanghøj P; Cialdella P; Andersen HF; Pedersen AG Int J Neuropsychopharmacol; 2004 Sep; 7(3):283-90. PubMed ID: 15320956 [TBL] [Abstract][Full Text] [Related]
54. Effect of psychiatric and other nonmotor symptoms on disability in Parkinson's disease. Weintraub D; Moberg PJ; Duda JE; Katz IR; Stern MB J Am Geriatr Soc; 2004 May; 52(5):784-8. PubMed ID: 15086662 [TBL] [Abstract][Full Text] [Related]
55. A randomized controlled trial of the efficacy and safety of lisdexamfetamine dimesylate as augmentation therapy in adults with residual symptoms of major depressive disorder after treatment with escitalopram. Trivedi MH; Cutler AJ; Richards C; Lasser R; Geibel BB; Gao J; Sambunaris A; Patkar AA J Clin Psychiatry; 2013 Aug; 74(8):802-9. PubMed ID: 24021497 [TBL] [Abstract][Full Text] [Related]
56. Antidepressant Controlled Trial For Negative Symptoms In Schizophrenia (ACTIONS): a double-blind, placebo-controlled, randomised clinical trial. Barnes TR; Leeson VC; Paton C; Costelloe C; Simon J; Kiss N; Osborn D; Killaspy H; Craig TK; Lewis S; Keown P; Ismail S; Crawford M; Baldwin D; Lewis G; Geddes J; Kumar M; Pathak R; Taylor S Health Technol Assess; 2016 Apr; 20(29):1-46. PubMed ID: 27094189 [TBL] [Abstract][Full Text] [Related]
57. Executive function and short-term remission of geriatric depression: the role of semantic strategy. Morimoto SS; Gunning FM; Murphy CF; Kanellopoulos D; Kelly RE; Alexopoulos GS Am J Geriatr Psychiatry; 2011 Feb; 19(2):115-22. PubMed ID: 20808124 [TBL] [Abstract][Full Text] [Related]
58. A randomized trial of citalopram versus placebo in outpatients with asthma and major depressive disorder: a proof of concept study. Brown ES; Vigil L; Khan DA; Liggin JD; Carmody TJ; Rush AJ Biol Psychiatry; 2005 Dec; 58(11):865-70. PubMed ID: 15993860 [TBL] [Abstract][Full Text] [Related]
59. A Randomized, Double-Blind, Placebo-Controlled Trial of Escitalopram in Patients with Asthma and Major Depressive Disorder. Brown ES; Sayed N; Van Enkevort E; Kulikova A; Nakamura A; Khan DA; Ivleva EI; Sunderajan P; Bender BG; Holmes T J Allergy Clin Immunol Pract; 2018; 6(5):1604-1612. PubMed ID: 29409976 [TBL] [Abstract][Full Text] [Related]
60. Combined treatment with methylphenidate and citalopram for accelerated response in the elderly: an open trial. Lavretsky H; Kim MD; Kumar A; Reynolds CF J Clin Psychiatry; 2003 Dec; 64(12):1410-4. PubMed ID: 14728100 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]